⚠️ Product Information Only: This page describes a product and provides an affiliate link. It is not a recommendation to buy or use it. Always consult a qualified healthcare professional before starting any supplement.
Welzo NMNH Advanced NAD+ Formula 500mg
A reduced-form NAD+ precursor for evidences interested in next-generation NAD+ boosters.
Image: product illustration based on Amazon listing.
★★★★★
4.5 / 5 based on Amazon customer reviews
From ~£24.99 on Amazon
Welzo NMNH delivers 500mg of reduced-form nicotinamide mononucleotide (NMNH) per serving. NMNH is a newer NAD+ precursor that, in cell and mouse studies, raised NAD+ more potently than standard NMN and NAD+ precursors. Human clinical data are still emerging.
Claim: 4x stronger NAD+ precursor vs NMN (cell/mouse data)
Key benefits marketed: Cellular energy, healthy ageing, NAD+ support
Seller: Amazon / Welzo
What Is NMNH?
NMNH stands for dihydronicotinamide mononucleotide, the reduced form of NMN. Standard NMN must be converted into NAD+ inside cells; NMNH appears to be converted more efficiently in preclinical models, producing larger rises in intracellular NAD+ from a smaller dose.
In the landmark 2021 FASEB Journal study, NMNH was described as a "new and potent NAD+ precursor in mammalian cells and mice." Researchers observed that NMNH raised NAD+ faster and to higher levels than NMN in cultured cells, and that oral NMNH increased liver NAD+ in mice.
🐢 Tortoise Wisdom
"NMNH is exciting in the lab, but the lab is not your living room. Human proof still matters."
Human Evidence: Where Are We?
As of 2026, peer-reviewed human trials of NMNH are limited. EffePharm's UthPeak NMNH trial (NCT06889740) was completed with 80 healthy adults, evaluating safety, tolerability and pharmacokinetics, but full published results are not yet widely available. A 2026 Nature Metabolism Overview of NAD+ precursor supplementation in human ageing notes that evidence for NAD+ boosters improving clinical outcomes in healthy adults remains mixed, regardless of precursor type.
In short: NMNH has stronger preclinical potency data than human outcome data. Treat marketing claims of "4x stronger" as referring to cell and mouse studies, not proven effects in people.
Welzo NMNH 500mg Overview — visual guide from LongevityTortoise.
Product Overview
We are reviewing Welzo NMNH because it is one of the few-listed NMNH products with a clear 500mg dose, simple formulation and Amazon-backed delivery. It is a good option for readers who want to experiment with a next-generation NAD+ precursor, provided they understand the limited human evidence.
✅ Pros
Clear 500mg NMNH dose per serving
Reduced-form precursor with promising preclinical data
delivery via Amazon Prime
Simple single-ingredient formula
⚠️ Considerations
Human clinical data are preliminary
Long-term safety at 500mg/day is not established
"4x stronger" claim refers to cells/mice, not humans
What the Research Says
Zapata-Pérez et al., 2021 — FASEB Journal
"Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice." Showed NMNH raised NAD+ more potently than NMN in cells and increased liver NAD+ in mice.
View DOI
UthPeak NMNH Trial, 2025 — NCT06889740
Industry-sponsored randomised trial in 80 healthy adults evaluating safety, tolerability and pharmacokinetics of NMNH. Full peer-reviewed results pending.
View ClinicalTrials.gov
Overview, 2025 — Nature Metabolism
"NAD+ precursor supplementation in human ageing: clinical evidence and challenges." Notes mixed evidence for NAD+ boosters improving clinical outcomes in healthy adults.
View Article
Read our full guides on NMN & NAD+ precursors and NR vs NMN.
Summary
Welzo NMNH 500mg is a strong preclinical candidate packaged for everyday evidences. If you are already comfortable with NAD+ precursors and want to try the newest form, this is a transparent option. Just keep expectations realistic: potency in cells and mice does not guarantee benefits in humans.
NMN & NAD+ Precursors: What the 2026 Evidence Actually Says
NAD+ Precursors Compared: NR vs NMN for Longevity (UK)
NMNH Supplements in 2026: Evidence on the New NAD+ Precursor
Frequently Asked Questions
What is Welzo NMNH 500mg?
Welzo NMNH 500mg is an evidence-based LongevityTortoise resource for readers interested in healthy ageing. Independent research summaries; consult a healthcare professional before changing supplements or health regimen.
Is the information on this page medical advice?
No. Independent research summaries; consult a healthcare professional before changing supplements or health regimen.
How does LongevityTortoise choose topics?
We focus on peer-reviewed papers, human trials, preprints and regulatory updates relevant to UK readers. We disclose affiliate links and conflicts of interest.
Are supplements recommended on this page?
We review supplements as informational products only. They are not personal recommendations. Always check with a qualified healthcare professional before starting a supplement.
Where can I find related LongevityTortoise articles?
Use the related-links section near the bottom of the page, the site navigation or our sitemap.
